Jane Street Group, LLC Atara Biotherapeutics, Inc. Call Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$8.44 - $16.89 $7,596 - $15,201	-900 Reduced 4.33%	19,900 $185,000
Q4 2021 Feb 15, 2022	BUY	$14.7 - $19.89 $155,820 - $210,834	10,600 Added 103.92%	20,800 $328,000
Q3 2021 Nov 16, 2021	SELL	$11.99 - $17.9 $51,557 - $76,970	-4,300 Reduced 29.66%	10,200 $183,000
Q4 2020 Feb 17, 2021	BUY	$12.67 - $26.23 $183,715 - $380,335	14,500 New	14,500 $285,000
Q2 2018 Aug 15, 2018	SELL	$35.15 - $51.45 $618,640 - $905,520	-17,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$18.0 - $48.35 $316,800 - $850,960	17,600 New	17,600 $686,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.